A prospective study investigating the impact of preoperative treatment on the anti-tumor efficacy and disease-free survival for Chinese melanoma
Latest Information Update: 12 Jun 2020
At a glance
- Drugs Pembrolizumab (Primary) ; Toripalimab (Primary) ; Vemurafenib (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
Most Recent Events
- 12 Jun 2020 New trial record
- 31 May 2020 Results presented at the 56th Annual Meeting of the American Society of Clinical Oncology